60% of Revenue from Wang Yibo? YH ENT Responds: Proportion Gradually Declining

Deep News11-06

On November 6, recent reports claimed that Wang Yibo would not renew his contract with YH ENT upon expiration. Sources indicated that in 2024, YH ENT's total revenue reached 765 million yuan, with Wang Yibo—dubbed the "top cash cow"—contributing over 60%. Additional data revealed that his contribution has surged annually since 2019, rising from 16.8% in 2019 to 56.8% in 2022 and hitting the 60% mark in 2024.

When asked whether Wang Yibo's potential departure would impact the company's stock price, YH ENT's investor relations department stated, "The current stock performance remains stable, with recent gains." They added, "His (Wang Yibo) revenue share within the company is gradually decreasing, and his contract was originally set to expire next year. Please await our official announcement at that time."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment